THE APEX TIMES
Target recalls Up & Up baby wipes after FDA testing finds potentially harmful bacteria
The company is pulling specific sizes and lot/date-code ranges of its store-brand wipes, citing customer complaints of discoloration and FDA-identified contamination with Burkholderia cepacia complex and Burkholderia gladioli.
Target said it is voluntarily recalling select Up & Up baby wipes nationwide after customer complaints about discoloration and subsequent FDA testing identified Burkholderia cepacia complex and Burkholderia gladioli in product samples. The recall covers two varieties: Up & Up Fragrance Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes, sold at Target stores nationwide and. FDA recall announcement.
The FDA notice lists the affected products by size, UPC, and manufacturing/expiration code ranges, rather than recalling the entire line. For example, the fragrance-free option includes 20-count (UPC 085239265956) through 1200-count (UPC 085239266090), while the cucumber-scented wipes include 72-count (UPC 085239265970), 216-count (UPC 085239265994), and 800-count (UPC 085239265987). Target instructed consumers to stop using the recalled wipes and return them to any Target store for a full refund, and provided a Guest Relations number for questions. FDA recall announcement.
In its health-risk language, the FDA said use of products contaminated with the identified Burkholderia organisms may result in serious and life-threatening infections - particularly because the wipes are predominantly used on newborns, infants, and young children. The agency warned that, in healthy individuals, minor skin lesions may lead to more local infections, while in immunocompromised individuals the infection is more likely to spread into the bloodstream, potentially leading to sepsis or pneumonia. FDA recall announcement.
Target also posted the recall on its own consumer-facing “Product recalls” page, listing the Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes under its most recent recalls. The listing includes the recall date of 6/4/2026, aligning with the FDA-documented announcement timeline. Target product recalls page.
From a business standpoint, the recall highlights the operational and quality-control burden that can come with selling private-label personal-care items: Target said the wipes were produced by a supplier and that the company and the manufacturer, Sapro Temizlik Urunleri, have received consumer complaints and adverse event reports alleging discoloration, irritation, and infections that may be associated with the wipes. The FDA notice also states the reports “remain under investigation,” and Target said it continues to coordinate with the manufacturer and investigate the matter. FDA recall announcement.
What investors and customers will likely watch next is whether Target provides additional detail on the investigation - such as whether the issue is confined strictly to the listed UPCs and date codes, or whether broader lot/date ranges come into scope. The FDA notice did not quantify recall-related costs (such as refund and logistics expenses) or provide a projected financial impact, so future updates may matter more for evaluating operational exposure than the initial headline. FDA recall announcement.
Why It Matters
- The recall adds near-term customer-service and reverse-logistics pressure around a high-velocity store-brand category.
- Because the affected products are identified by specific UPCs and date codes, the ultimate scope of remediation may be constrained - but customers may still need guidance to confirm whether their packages are included.
- The episode can increase scrutiny of supplier manufacturing controls for Target’s private-label personal-care items.
- While headlines can move retail sentiment, the absence of disclosed dollar estimates in the FDA posting means later company updates could be the key driver of market reaction.
Sources
Key Facts
- Target announced a voluntary nationwide recall on June 4, 2026 of select Up & Up Fragrance Free and Fresh Cucumber Scented baby wipes.
- The FDA said testing identified contamination with Burkholderia cepacia complex and Burkholderia gladioli in product samples.
- The recall is limited by UPC and manufacturing/expiration code ranges, rather than covering every unit of the product lines.
- Target told consumers to stop using the affected wipes and return them to any Target store for a full refund.
- The FDA warned the bacteria may cause serious or life-threatening infections, especially for newborns, infants, young children, and immunocompromised individuals.
- Target stated it is coordinating with the manufacturer, Sapro Temizlik Urunleri, and that adverse event reports are under investigation.
Retail & Consumer Related
McDonald’s and Taco Bell take aim at the afternoon slump with fresh energy drink launches
Both chains have rolled out new energy drink options within days of each other, turning a familiar 3 p.m. craving into a crowded, brand-distinction race.
Walmart settlement sheds light on scale of opioid-related pharmacy dispute, costing about 0.4% of six-month profit
A Justice Department dispute involving Walmart pharmacies and opioid prescriptions ended in a settlement that, according to market coverage, landed at a small fraction of the retailer’s earnings over a six-month period.
Walmart ends DOJ opioid case with far smaller payout than sought, calling it “immaterial”
A lawsuit that faced a potential multibillion-dollar penalty for Walmart pharmacies closed with a settlement amount described by the company as modest relative to the risk that was on the table.
Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers
Investors are treating cheaper-to-own retail as a buffer again, after a sharp move in crude oil toward $90. The shift could help Walmart capture shoppers “trading down,” but higher fuel and inventory costs also pose a risk to the cash profits that support its valuation.
Walmart Marketplace Momentum Pressures Brick-and-Mortar Limits, With U.S. Sales Jumping 52%, Report Says
A surge in Walmart’s U.S. marketplace sales, alongside wider assortment, greater use of Walmart fulfillment, and expansion into Mexico and Canada, is putting fresh focus on whether the company can keep accelerating its third-party platform.
Nike reinstates a chief commercial officer role, naming Walmart veteran Jane Ewing
Nike appointed Jane Ewing, a longtime retailer executive, as chief commercial officer and brought back a dedicated executive role after a period without one, according to a report dated Aug. 31, 2026.